(FDS) FactSet Research Systems - Overview
Sector: Financial Services | Industry: Financial Data & Stock Exchanges | Exchange: NYSE (USA) | Market Cap: 8.149m USD | Total Return: -49.2% in 12m
Avg Turnover: 174M
EPS Trend: 90.7%
Qual. Beats: 0
Rev. Trend: 99.8%
Qual. Beats: 4
Warnings
No concerns identified
Tailwinds
Confidence
FactSet Research Systems Inc. (FDS) is a global provider of integrated financial data, analytical applications, and enterprise solutions. The company operates primarily through a subscription-based model, delivering market intelligence and workflow tools to institutional asset managers, investment bankers, and wealth managers across the Americas, EMEA, and Asia Pacific regions.
The company’s platform covers the entire investment lifecycle, including portfolio construction, risk management, and trade execution. FactSet competes in the financial information services sector, a high-barrier-to-entry industry characterized by high recurring revenue and deep integration into client workflows. Its delivery methods include cloud-based digital solutions, mobile platforms, and application programming interfaces (APIs) for enterprise data integration.
For a deeper look into the companys valuation metrics and historical performance, consider reviewing the detailed reports on ValueRay. Founded in 1978 and headquartered in Norwalk, Connecticut, FactSet continues to focus on consolidating fragmented financial data sets into unified workstations for investment professionals.
- Subscription retention rates among institutional asset managers drive recurring revenue stability
- Expansion of wealth management and private equity solutions captures new market share
- Integration of generative AI tools increases platform value and user efficiency
- Global financial market volatility impacts buy-side and sell-side technology spending budgets
- Strategic acquisitions and cloud-based delivery models influence long-term operating margins
| Net Income: 587.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 2.87 > 1.0 |
| NWC/Revenue: 8.38% < 20% (prev 10.02%; Δ -1.63% < -1%) |
| CFO/TA 0.19 > 3% & CFO 798.9m > Net Income 587.8m |
| Net Debt (1.47b) to EBITDA (951.9m): 1.54 < 3 |
| Current Ratio: 1.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.1m) vs 12m ago -3.76% < -2% |
| Gross Margin: 51.94% > 18% (prev 0.54%; Δ 5.14k% > 0.5%) |
| Asset Turnover: 56.75% > 50% (prev 53.15%; Δ 3.61% > 0%) |
| Interest Coverage Ratio: 9.22 > 6 (EBITDA TTM 951.9m / Interest Expense TTM 81.2m) |
| A: 0.05 (Total Current Assets 707.2m - Total Current Liabilities 505.9m) / Total Assets 4.22b |
| B: 0.60 (Retained Earnings 2.53b / Total Assets 4.22b) |
| C: 0.18 (EBIT TTM 748.5m / Avg Total Assets 4.23b) |
| D: 1.18 (Book Value of Equity 2.46b / Total Liabilities 2.09b) |
| Altman-Z'' = 4.69 = AA |
| DSRI: 1.08 (Receivables 320.2m/277.6m, Revenue 2.40b/2.25b) |
| GMI: 1.04 (GM 51.94% / 54.15%) |
| AQI: 1.03 (AQ_t 0.81 / AQ_t-1 0.79) |
| SGI: 1.07 (Revenue 2.40b / 2.25b) |
| TATA: -0.05 (NI 587.8m - CFO 798.9m) / TA 4.22b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of May 26, 2026, the stock is trading at USD 232.00 with a total of 498,795 shares traded.
Over the past week, the price has changed by +9.14%,
over one month by +2.96%,
over three months by +12.86% and
over the past year by -49.16%.
FactSet Research Systems has received a consensus analysts rating of 2.67. Therefore, it is recommended to hold FDS.
- StrongBuy: 2
- Buy: 0
- Hold: 12
- Sell: 3
- StrongSell: 4
| Analysts Target Price | 252.4 | 8.8% |
P/E Trailing = 14.3846
P/E Forward = 11.1607
P/S = 3.3939
P/B = 3.7974
P/EG = 1.0532
Revenue TTM = 2.40b USD
EBIT TTM = 748.5m USD
EBITDA TTM = 951.9m USD
Long Term Debt = 1.37b USD (from longTermDebt, last quarter)
Short Term Debt = 39.2m USD (from shortTermDebt, last quarter)
Debt = 1.74b USD (from shortLongTermDebtTotal, last quarter) + Leases 184.4m
Net Debt = 1.47b USD (calculated: Debt 1.74b - CCE 268.3m)
Enterprise Value = 9.62b USD (8.15b + Debt 1.74b - CCE 268.3m)
Interest Coverage Ratio = 9.22 (Ebit TTM 748.5m / Interest Expense TTM 81.2m)
EV/FCF = 14.09x (Enterprise Value 9.62b / FCF TTM 682.9m)
FCF Yield = 7.10% (FCF TTM 682.9m / Enterprise Value 9.62b)
FCF Margin = 28.44% (FCF TTM 682.9m / Revenue TTM 2.40b)
Net Margin = 24.48% (Net Income TTM 587.8m / Revenue TTM 2.40b)
Gross Margin = 51.94% ((Revenue TTM 2.40b - Cost of Revenue TTM 1.15b) / Revenue TTM)
Gross Margin QoQ = 51.43% (prev 52.62%)
Tobins Q-Ratio = 2.28 (Enterprise Value 9.62b / Total Assets 4.22b)
Interest Expense / Debt = 4.67% (Interest Expense 81.2m / Debt 1.74b)
Taxrate = 17.41% (28.1m / 161.1m)
NOPAT = 618.2m (EBIT 748.5m * (1 - 17.41%))
Current Ratio = 1.40 (Total Current Assets 707.2m / Total Current Liabilities 505.9m)
Debt / Equity = 0.82 (Debt 1.74b / totalStockholderEquity, last quarter 2.13b)
Debt / EBITDA = 1.54 (Net Debt 1.47b / EBITDA 951.9m)
Debt / FCF = 2.15 (Net Debt 1.47b / FCF TTM 682.9m)
Total Stockholder Equity = 2.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.89% (Net Income 587.8m / Total Assets 4.22b)
RoE = 27.22% (Net Income TTM 587.8m / Total Stockholder Equity 2.16b)
RoCE = 21.21% (EBIT 748.5m / Capital Employed (Equity 2.16b + L.T.Debt 1.37b))
RoIC = 16.97% (NOPAT 618.2m / Invested Capital 3.64b)
WACC = 6.69% (E(8.15b)/V(9.89b) * Re(7.29%) + D(1.74b)/V(9.89b) * Rd(4.67%) * (1-Tc(0.17)))
Discount Rate = 7.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.39 | Cagr: -1.84%
[DCF] Terminal Value 77.97% ; FCFF base≈635.6m ; Y1≈728.7m ; Y5≈1.07b
[DCF] Fair Price = 402.6 (EV 16.1b - Net Debt 1.47b = Equity 14.7b / Shares 36.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.73 | EPS CAGR: 6.44% | SUE: 0.48 | # QB: 0
Revenue Correlation: 99.79 | Revenue CAGR: 5.61% | SUE: 1.31 | # QB: 4
EPS current Quarter (2026-05-31): EPS=4.45 | Chg30d=+1.04% | Revisions=+56% | Analysts=16
EPS current Year (2026-08-31): EPS=17.71 | Chg30d=+0.00% | Revisions=+73% | GrowthEPS=+4.3% | GrowthRev=+6.1%
EPS next Year (2027-08-31): EPS=19.42 | Chg30d=+0.00% | Revisions=+73% | GrowthEPS=+9.6% | GrowthRev=+5.6%
[Analyst] Revisions Ratio: +73%